Discover Opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis
Office of Acquisition Managementt Policy
This contract includes 1 purchase order from Sep 22, 2024 to Sep 22, 2024
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| Office of Acquisition Managementt Policy | AD ASTRA DIAGNOSTICS, INC. | Sep 22, 2024 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
Office of Acquisition Managementt Policy
OXIVAX - AOI #28: INFLUENZA VACCINE INNOVATION. ADVANCING METAGENOMIC NEXT-GENERATION SEQUENCING BASED AGNOSTIC DIAGNOSTICS FOR VIRAL PATHOGENS THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PREPARE THE IND PACKAGE FOR OVX836+SQ ADJUVANT.
Effective Date
Sep 30, 2025
Expires
Effective: Sep 30, 2025
Office of Acquisition Managementt Policy
Expires:
OXIVAX - AOI #28: INFLUENZA VACCINE INNOVATION. ADVANCING METAGENOMIC NEXT-GENERATION SEQUENCING BASED AGNOSTIC DIAGNOSTICS FOR VIRAL PATHOGENS THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PREPARE THE IND PACKAGE FOR OVX836+SQ ADJUVANT.
ActiveOffice of Acquisition Managementt Policy
EXECUTION OF THE CLINICAL METHOD COMPARISON STUDY AND REGULATORY SUBMISSION REQUIRED TO BE GRANTED CLIA-WAIVER FROM THE FDA FOR FEBRIDX RESPONSE TO BAA-23-100-SOL-00004
Effective Date
Sep 25, 2024
Expires
Effective: Sep 25, 2024
Office of Acquisition Managementt Policy
Expires:
EXECUTION OF THE CLINICAL METHOD COMPARISON STUDY AND REGULATORY SUBMISSION REQUIRED TO BE GRANTED CLIA-WAIVER FROM THE FDA FOR FEBRIDX RESPONSE TO BAA-23-100-SOL-00004
ActiveOffice of Acquisition Managementt Policy
AOI #23+: HOST-BASED DIAGNOSTICS - EXPANSION OF IMMUNIX PLATFORM FOR PRECISION MEDICINE IN SEVERE ACUTE RESPIRATORY INFECTIONS AND ARDS
Effective Date
Sep 30, 2025
Expires
Effective: Sep 30, 2025
Office of Acquisition Managementt Policy
Expires:
AOI #23+: HOST-BASED DIAGNOSTICS - EXPANSION OF IMMUNIX PLATFORM FOR PRECISION MEDICINE IN SEVERE ACUTE RESPIRATORY INFECTIONS AND ARDS
ActiveOffice of Acquisition Managementt Policy
CURIEDX - RESEARCH AND DEVELOPMENT FOR AOI #17 - TRANSFORMING RESPIRATORY INFECTION SURVEILLANCE WITH COMPUTER VISION ON A SMARTPHONE
Effective Date
Jun 28, 2024
Expires
Effective: Jun 28, 2024
Office of Acquisition Managementt Policy
Expires:
CURIEDX - RESEARCH AND DEVELOPMENT FOR AOI #17 - TRANSFORMING RESPIRATORY INFECTION SURVEILLANCE WITH COMPUTER VISION ON A SMARTPHONE
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis